Navigation Links
Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
Date:5/20/2008

y and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases, the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy and the Society for Surgery of the Alimentary Tract, DDW takes place May 17-22, 2008, at the San Diego Convention Center, San Diego, CA. The meeting showcases approximately 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. For more information, visit http://www.ddw.org.

THE "SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward- looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research, product development including, but not limited to the successful development of JUVISTA(R) (Human TGFB3) and veleglucerase alfa (GA-GCB); manufacturing and commercialization including, but not limited to, the establishment in the market of VYVANSE(TM) (lisdexamfetamine dimesylate) (Attention Deficit and Hyperactivity Disorder ("ADHD")); the impact of competitive products, including, but not limited to, the impact of those on Shire's ADHD franchise; patents, including but not limited to, legal challenges relating to Shire's ADHD franchise; government regulation and approval, including but not limited to the expected product approval date of INTUNIV(TM) (guanfacine extended release) (ADHD); Shire's ability to secure new products for commercialization and/or development; and other risks and uncertainties detailed from time to time in Shire plc's fili
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... According to a new market ... Advanced, Ultrasound), Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices ... WPW) - Global Forecasts to 2019 ", published by MarketsandMarkets, ... ~$4.73 Billion by 2019 with a CAGR of around ... Browse   90   ma rket ...
(Date:3/27/2015)... , March 27, 2015 As ... shipments of incontinence devices for women. ... the most gratifying part is the hundreds of ... women whose lives have been positively impacted by ... of InControl. InControl recently released Apex, ...
(Date:3/27/2015)... The International Myeloma Foundation (IMF) – improving ... toward prevention and a cure – today commended Representative ... resolution (H. Res. 174) that supports the designation of ... Awareness Month." Currently there are more than ... 110,000 new cases are diagnosed yearly, according to the ...
Breaking Medicine Technology:Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... May 5 OrthoAccel Technologies, Inc. announced that it has entered ... to introduce the AcceleDent System to the Australian market. , ... (Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO ) , ... AcceleDent, an acceleration device to enhance orthodontics, was introduced ...
... Instrumentation Laboratory (IL) today announced total worldwide sales in 2009 ... growth v. previous year in current, and 13.2% in local currencies.  In ... growth in local currencies was 13.2% and 12.4%, respectively. , ... "In spite of the major economic downturn, ...
Cached Medicine Technology:OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction 2OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction 3OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction 4Instrumentation Laboratory Achieves Record Sales in 2009 2Instrumentation Laboratory Achieves Record Sales in 2009 3
(Date:3/27/2015)... Omaha, NE (PRWEB) March 27, 2015 Ticket ... tickets at the CenturyLink Center in Omaha, Nebraska on ... a possibility that more concert dates will be added in ... result of fan demand. , The Garth Brooks World Tour ... with the latest announcement that Garth Brooks and Trisha Yearwood ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 According to ... http://www.idataresearch.com ), the plate and screw market in Europe ... the generic plate and screw segment. Price decreases are ... Despite representing almost 50% of the total European trauma ... decrease the total market value, year after year. ...
(Date:3/27/2015)... LONDON, UK (PRWEB) March 27, 2015 ... SiteStart Melissa (Liss) Easy was named to the 2015 ... 40 Under 40 list spotlights 40 dynamic, up-and-coming leaders ... accomplishments and community involvement. Winners are honored at an ... supplement of the Philadelphia Business Journal. , Lyn Kremer, ...
(Date:3/27/2015)... On March 19, 2015, at Detroit’s ... wide receiver Herman Moore, hosted “Fighting Addiction Together,” ... abuse, treatment options and the recent changes in ... ministers and bishops from local churches as well ... “Our ‘Fighting Addiction Together’ luncheon was informative and ...
(Date:3/27/2015)... CA (PRWEB) March 27, 2015 Endure ... Yoga for functional fitness athletes. This new program matches ... specific protocol for post-workout cool down. This program utilizes ... breath control and mental focus. , Karen Lefurgy, ... started practicing yoga long before I started Crossfit® training, ...
Breaking Medicine News(10 mins):Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 3Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 2Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 3Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:LiveToBeSober.org Hosts Conference on Substance Abuse Treatment and Recovery at Ford Field 2Health News:Endure Yoga Introduces WOD Recovery Yoga 2
... In medical breakthrough research findings, researchers have been able ... which had significant brain degeneration. ,Researchers from University ... so that the mice have a clinical condition very ... researchers used transgene to check the loss of memory. ...
... form of the enzyme aldehyde dehydrogenase// (ALDH)that is responsible ... consuming alcohol. ,Researchers from Mitsukoshi Health and Welfare ... to hangovers in individuals who have a particular genetic ... important enzyme involved in the removal of acetaldehyde, which ...
... women with sexual difficulties was rejected by a panel of ... ,Procter & Gamble, global manufacturer of household products, ... menopausal after ovarian surgery however due to the rejection by ... hold until more data is available to assess the drug. ...
... a “black box warning” to three asthma drugs//, ... advised the manufacturers that the drug should carry ... breathing. ,Adavir and Serevent are manufactured ... manufacturers the drug Foradil which contains a different ...
... constantly coming up with new strategies// and technologies to ... ,Deputy director BK Karna of Indian Institute ... bring in novel features to prevent proliferation of duplicated ... closure and tamper evidence packaging they are yet to ...
... University of California-San Francisco has published that weight loss// ... by increasing heart beat rate and blood pressure. ... homeostasis. ,The study spearheaded by Dr. Christine A. ... experimental group of 16 healthy adults. Two tests were ...
Cached Medicine News:Health News:Testosterone patch for women Rejected For safety Reasons 2Health News:FDA gives “black box warning” against three asthma dru 2Health News:The Use of Radio Frequency Identification ( RFID) to tackle the growing menace of counterfeit drugs 2
... OraQuick is an FDA ... venipuncture whole blood test used ... of HIV-1 infection. This CLIA ... presence of antibodies to HIV-1, ...
... QuickVue+ Infectious Mononucleosis test is ... antibodies in serum, plasma or whole ... utilizes an extract of bovine erythrocytes ... specificity than similar extracts prepared from ...
... the first available point-of-care diagnostic test that ... of influenza A and B. The test ... an enzyme that assists viral replication by ... infected cells. The ZstatFlu substrate is labeled ...
The NOW Flu A test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results and tre...
Medicine Products: